Core Insights - Columbia Threadneedle Investments reported a 12.06% return for its Columbia Global Technology Growth Fund in Q3 2025, slightly below the S&P Global 1200 Information Technology Index's return of 12.82% [1] - The fund's performance was positively influenced by stock selection, particularly in the context of strong earnings growth and enthusiasm for artificial intelligence [1] Company Performance - ServiceNow, Inc. (NYSE:NOW) experienced a one-month return of 0.71% and a 52-week decline of 3.70%, closing at $919.28 per share with a market capitalization of $191.349 billion on October 31, 2025 [2] - The company reported third-quarter subscription revenues of $3.299 billion, reflecting a 20.5% year-over-year growth in constant currency [4] Strategic Positioning - ServiceNow's recent underperformance was attributed to cautious guidance that raised concerns about delayed renewal deals from large clients [3] - Despite challenges, ServiceNow's AI innovations are gaining traction, positioning the company as a next-gen workflow and AI orchestration platform [3]

POTOMAC, MARYLAND / ACCESS Newswire / November 3, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today announced an expansion of its AI-powered in-Silico drug discovery platform. The company is now integrating more methodologies, including retrosynthetic analysis, molecular docking, toxicology and genotoxic assessments, and predictive bioactivity modeling, to a ...

The Palantir stock price soared to a record high last week, raising valuation eyebrows, as traders waited for the upcoming financial results, which will provide more information about its business. P... ...

Key Points Tesla's expenses are rising and earnings are falling at the same time that EV tax credits have expired. Ferrari continues to enjoy an operating margin of around 29% and demand for its supercars remains sky high. Ferrari looks like the better stock on multiple fronts. 10 stocks we like better than Ferrari › Ferrari (NYSE: RACE) and Tesla (NASDAQ: TSLA) have been two of the most popular automotive stocks over the past decade, with each of them carving out a unique niche in the auto space. ...

[Music] Welcome to the Green Stock News Brief for Monday, November 3rd. Here are today's top headlines. Lee Auto delivered 32,000 vehicles in October, bringing its total deliveries to 1,460,000 and continues to see strong demand for the Lei 6 with over 70,000 orders.The company is accelerating global expansion with new stores opening while operating over 550 retail locations and 3,500 supercharging stations across China. Xpang delivered a record 42,000 smart EVs in October, marking a 76% year-over-year incr ...

Core Viewpoint - Volatus Aerospace Inc. has restated its financial statements for the three and six months ended June 30, 2025, reflecting a non-cash, one-time accounting adjustment of $2,231,202 related to balance sheet restructuring, with no impact on revenue, gross margin, or cash position [1][2][3]. Financial Summary - The restatement includes a non-cash accounting adjustment of $2,231,202 due to restructuring and modification of debt instruments [2][3]. - The company's revenue for the quarter remains at $10,587,075, with a gross margin of 32% [2][3]. - The adjustment is characterized as a one-time charge and does not affect the company's operational performance [2][3]. Corporate Governance - The CFO of Volatus Aerospace emphasized the company's commitment to transparency and accuracy in financial reporting [3]. - The restated financial statements and management's discussion and analysis have been filed on SEDAR+ and are accessible on the company's website [3]. Future Outlook - The company anticipates the Government of Canada's budget announcement on November 4, 2025, which may have implications for its operations [4]. Company Overview - Volatus Aerospace is a leader in aerial intelligence and cargo solutions, serving various industries including oil and gas, energy utilities, healthcare, public safety, and infrastructure [5]. - The company focuses on enhancing operational efficiency, safety, and sustainability through advanced aerial technologies [5].

Below is a brief overview of the movements of various asset classes from yesterday, last week, and the previous month.BIRMINGHAM, ENGLAND - DECEMBER 13: A jewellery quarter gold dealer poses with three 1kg gold bullion bars on December 13, 2023 in Birmingham, England. Gold prices have increased since the Ukraine War but have soared to record highs since the start of the Hamas-Israel war. Other factors are the weakening US dollar and expected rate cuts from the Federal Reserve. (Photo by Christopher Furlong/ ...

Core Insights - TG Therapeutics reported adjusted earnings of $2.43 per share and $161.7 million in sales for Q3, significantly exceeding analyst expectations of $0.22 earnings per share and $152.1 million in sales [1][2] - The earnings beat was primarily attributed to a one-time tax benefit of $365 million, which, if excluded, would have resulted in earnings closer to $0.15 per share [2] - The company raised its full-year sales guidance to $600 million, with $585 million expected from U.S. sales of its multiple sclerosis drug Briumvi [3] Financial Performance - Q3 adjusted earnings: $2.43 per share [1] - Q3 sales: $161.7 million [1] - Analyst expectations: $0.22 earnings per share and $152.1 million in sales [2] - Previous year Q3 earnings: $0.02 per share and $83.9 million in sales [2] - Revised full-year sales guidance: $600 million [3] Market Reaction - TG Therapeutics stock increased by 4.4% to $36.30 in premarket trading [3] - Shares are trading slightly above their 50-day moving average [3] Ratings and Upgrades - TG Therapeutics received an upgrade in its IBD SmartSelect Composite Rating from 94 to 97 [4][7] - The company is now part of an elite list of stocks with a composite rating above 95 [7]

Core Insights - Ucore Rare Metals Inc. has signed a Memorandum of Understanding (MOU) with Vacuumschmelze GmbH & Co. KG and eVAC Magnetics LLC to develop a collaborative supply agreement for high-purity rare earth oxides (REOs) [1][4][6] - The partnership aims to secure a stable supply of REOs critical for various industries, including automotive, industrial automation, and defense systems [3][6][7] - Ucore's RapidSX™ refining technology will play a vital role in producing the necessary REOs for VAC and eVAC's operations [6][10] Company Overview - Ucore is advancing North American rare earth separation and refining through its Louisiana Strategic Metals Complex and commercialization of RapidSX™ separation technology [10] - The company received a follow-on award of US$18.4 million from the U.S. Department of Defense in 2025, bringing total funding under its current agreement to US$22.4 million [10] Strategic Importance - The collaboration is expected to enhance the strategic position of VAC and eVAC in the global rare earth supply chain, ensuring long-term access to critical raw materials [7] - The MOU was signed at the G7 Energy and Environment Minister's Summit, highlighting its significance on an international platform [8] Future Plans - The parties will define the structure and commercial terms for a definitive long-term agreement within nine months, supported by regular progress reviews [9]

Core Viewpoint - A class action lawsuit has been filed against Fluor Corporation (FLR) by Berger Montague on behalf of investors who acquired shares between February 18, 2025, and July 31, 2025, due to alleged misrepresentation of the company's financial condition and undisclosed issues with major infrastructure projects [1][3]. Company Overview - Fluor Corporation, headquartered in Irving, Texas, provides engineering, procurement, construction, and project management services globally, with its Urban Solutions segment being the largest revenue contributor [2]. Allegations and Investigation - The investigation focuses on claims that FLR misrepresented its financial health and concealed escalating issues related to significant infrastructure projects, including rising costs and delays in the Gordie Howe, I-635/LBJ, and I-35 projects [3]. Financial Performance - On August 1, 2025, FLR reported disappointing Q2 2025 results, with earnings per share (EPS) of $0.43 and revenue of $3.98 billion, missing consensus estimates by $0.13 and $570 million, respectively. The company reduced its full-year forecast, attributing the shortfall to project execution failures and a slowdown in new contract awards. Following this announcement, FLR's stock price fell over 27%, closing at $41.42 on the same day [4]. Market Reaction - In response to the negative news, several brokerages downgraded FLR's stock, citing significant concerns regarding the company's internal controls and transparency [5].